Further encouraged by the parallel between COVID-19 and CF in terms of activation of both ENaC and TNFα/NFκB signaling, we have hypothesized that inflammation in the COVID-19 airway might be due to inhibition of CFTR signaling in normal lung epithelial cells by the SARS-CoV-2 spike protein. The gene discussed is NFKB1; the disease is COVID-19.